`a`
Mathematical Biosciences and Engineering (MBE)
 

Oncogene-tumor suppressor gene feedback interactions and their control
Pages: 1277 - 1288, Issue 6, December 2015

doi:10.3934/mbe.2015.12.1277      Abstract        References        Full text (590.5K)           Related Articles

Baltazar D. Aguda - DiseasePathways LLC, Bethesda, Maryland, 20814, United States (email)
Ricardo C.H. del Rosario - Computational and Systems Biology, Genome Institute of Singapore, 60 Biopolis St., #02-01 Genome, 138672, Singapore (email)
Michael W.Y. Chan - Department of Life Science & Institute of Molecular Biology, National Chung Cheng University, Min-Hsiung, China-Yi, Taiwan (email)

1 B. D. Aguda, Network pharmacology of glioblastoma, Curr Drug Discov Technol., 10 (2013), 125-138.
2 B. D. Aguda, The significance of the feedback loops between KRas and Ink4a in pancreatic cancer, in Molecular Diagnostics and Therapy of Pancreatic Cancer (ed. A. Azmi), Elsevier Academic Press, (2014), 281-296.
3 B. D. Aguda and A. B. Goryachev, From pathways databases to network models of switching behavior, PLoS Comput Biol., 3 (2007), 1674-1678.
4 B. D. Aguda, Y. Kim, H. S. Kim, A. Friedman and H. A. Fine, Qualitative network modeling of the Myc-p53 control system of cell proliferation and differentiation, Biophys J., 101 (2011), 2082-2091.
5 B. D. Aguda, Y. Kim, M. G. Piper-Hunter, A. Friedman and C. B. Marsh, MicroRNA regulation of a cancer network: Consequences of the feedback loops involving miR-17-92, E2F and Myc, Proc Natl Acad Sci USA, 105 (2008), 19678-19683.
6 R. C. Bast, B. Henessy and G. B. Mills, Jr., The biology of ovarian cancer: New opportunities for translation, Nat Rev Cancer, 9 (2009), 415-428.
7 Cancer Genome Atlas Research Network, Comprehensive genomic characterization defines human glioblastoma genes and core pathways, Nature, 494 (2013), p506.
8 Cancer Genome Atlas Research Network, Comprehensive molecular profiling of lung adenocarcinoma, Nature, 511 (2014), 543-550.
9 W. A. Cooper, D. C. Lam, S. A. O'Toole and J. D. Minna, Molecular biology of lung cancer, J Thorac Dis., 5 (2013), S479-S490.
10 J. Daniluk, Y. Liu, D. Deng, J. Chu, H. Huang, S. Gaiser, Z. Cruz-Monserrate, H. Wang, B. Ji and C. D. Logsdon, An NF-$\kappa$B pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice, J Clin Invest., 122 (2012), 1519-1528.
11 A. Dhooge, W. Govaerts and Y. A. Kuznetsov, MATCONT: A Matlab package for numerical bifurcation analysis of ODEs, ACM Trans Math Softw (TOMS), 29 (2003), 141-164.       
12 J. Drost and R. Agami, Transformation locked in a loop, Cell, 139 (2009), 654-656.
13 P. A. Futreal, L. Coin, M. Marshall, T. Down, T. Hubbard, R. Wooster, N. Rahman and M. R. Stratton, A census of human cancer genes, Nat Rev Cancer, 4 (2004), 177-183.
14 P. K. Ha, S. S. Chang, C. A. Glazer, J. A. Califano and D. Sidransky, Molecular techniques and genetic alterations in head and neck cancer, Oral Oncol, 45 (2009), 335-339.
15 http://cancer.sanger.ac.uk/cancergenome/projects/census/
16 http://ncg.kcl.ac.uk (network of cancer genes).
17 C. Kandoth, M. D. McLellan, F. Vandin, K. Ye, B. Niu, C. Lu, M. Xie, Q. Zhang, J. F. McMichael, M. A. Wyczalkowski, M. D. Leiserson, C. A. Miller, J. S. Welch, M. J. Walter, M. C. Wendl, T. J. Ley, R. K. Wilson, B. J. Raphael and L. Ding, Mutational landscape and significance across 12 major cancer types, Nature, 502 (2013), 333-339.
18 J. E. Larsen and J. D. Minna, Molecular biology of lung cancer: Clinical applications, Clin Chest Med., 32 (2011), 703-740.
19 E. Y. Lee and W. J. Muller, Oncogenes and tumor suppressor genes, Cold Spring Harb Perpect Biol., 2 (2010), a003236.
20 Y. Li, Y. Li, H. Zhang and Y. Chen, MicroRNA-mediated positive feedback loop and optimized bistable switch in a cancer network involving miR-17-92, PLoS One, 6 (2011), e26302.
21 P. Liao, W. Wang, M. Shen, W. Pan, K. Zhang, R. Wang, T. Chen, Y. Chen, H. Chen and P. Wang, A positive feedback loop between EBP2 and c-Myc regulates rDNA transcription, cell proliferation, and tumorigenesis, Cell Death Dis., 5 (2014), e1032.
22 L. Mao, W. K. Hong and V. A. Papadimitrakopoulou, Focus on head and neck cancer, Cancer Cell, 5 (2004), 311-316.
23 G. M. Marshall, P. Y. Liu, S. Gherardi, C. J. Scarlett, A. Bedalov, N. Xu, N. Iraci, E. Valli, D. Ling, W. Thomas, M. van Bekkum, E. Sekyere, K. Jankowski, T. Trahair, K. L. Mackenzie, M. Haber, M. D. Norris, A. V. Biankin, G. Perini and T. Liu, SIRT1 promotes N-Myc oncogenesis through a positive feedback loop involving the effects of MKP3 and ERK on N-Myc protein stability, PLoS Genet., 7 (2011), e1002135.
24 K. Nowak, K. Kerl, D. Fehr, C. Kramps, C. Gessner, K. Killmer, B. Samans, B. Berwanger, H. Christiansen and W. Lutz, BMI1 is a target gene of E2F-1 and is strongly expressed in primary neuroblastomas, Nucleic Acids Res., 34 (2006), 1745-1754.
25 B. Perez-OrdoƱez, M. Beauchemin and R. C. Jordan, Molecular biology of squamous cell carcinoma of the head and neck, J Clin Pathol., 59 (2006), 445-4453.
26 C. C. Pritchard and W. M. Grady, Colorectal cancer molecular biology moves into clinical practice, Gut., 60 (2011), 116-129.
27 T. Santarius, J. Shipley, D. Brewer, M. R. Stratton and C. S. Cooper, A census of amplified and overexpressed human cancer genes, Nat Rev Cancer, 10 (2010), 59-64.
28 K. Tago, M. Funakoshi-Tago, H. Itoh, Y. Furukawa, J. Kikuchi, T. Kato, K. Suzuki and K. Yanagisawa, Arf tumor suppressor disrupts the oncogenic positive feedback loop including c-Myc and DDX5, Oncogene, 34 (2015), 314-322.
29 P. Takahashi, A. Polson and D. Reisman, Elevated transcription of the p53 gene in early S-phase leads to a rapid DNA-damage response during S-phase of the cell cycle, Apoptosis, 16 (2011), 950-958.
30 D. Tamborero, A. Gonzalez-Perez, C. Perez-Llamas, J. Deu-Pons, C. Kandoth, J. Reimand, M. S. Lawrence, G. Getz, G. D. Bader, L. Ding and N. Lopez-Bigas, Comprehensive identification of mutational cancer driver genes across 12 tumor types, Sci Rep., 3 (2013), p2650.
31 M. Vauhkonen, H. Vauhkonen and P. Sipponen, Pathology and molecular biology of gastric cancer, Best Pract Res Clin Gastroenterol, 20 (2006), 651-674.

Go to top